JP2001521007A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521007A5
JP2001521007A5 JP2000517737A JP2000517737A JP2001521007A5 JP 2001521007 A5 JP2001521007 A5 JP 2001521007A5 JP 2000517737 A JP2000517737 A JP 2000517737A JP 2000517737 A JP2000517737 A JP 2000517737A JP 2001521007 A5 JP2001521007 A5 JP 2001521007A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000517737A
Other languages
Japanese (ja)
Other versions
JP2001521007A (ja
Filing date
Publication date
Priority claimed from GBGB9722682.3A external-priority patent/GB9722682D0/en
Application filed filed Critical
Publication of JP2001521007A publication Critical patent/JP2001521007A/ja
Publication of JP2001521007A5 publication Critical patent/JP2001521007A5/ja
Pending legal-status Critical Current

Links

Images

JP2000517737A 1997-10-27 1998-10-27 経口固体分散ワクチン組成物 Pending JP2001521007A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9722682.3 1997-10-27
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products
PCT/GB1998/003209 WO1999021579A1 (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery

Publications (2)

Publication Number Publication Date
JP2001521007A JP2001521007A (ja) 2001-11-06
JP2001521007A5 true JP2001521007A5 (enExample) 2009-05-21

Family

ID=10821162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000517737A Pending JP2001521007A (ja) 1997-10-27 1998-10-27 経口固体分散ワクチン組成物

Country Status (10)

Country Link
EP (1) EP1024824B1 (enExample)
JP (1) JP2001521007A (enExample)
AT (1) ATE274919T1 (enExample)
AU (1) AU9635998A (enExample)
DE (1) DE69826019T2 (enExample)
DK (1) DK1024824T3 (enExample)
ES (1) ES2227885T3 (enExample)
GB (1) GB9722682D0 (enExample)
PT (1) PT1024824E (enExample)
WO (1) WO1999021579A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5209160B2 (ja) 1999-08-24 2013-06-12 エービーアイシー・バイオロジカル・ラボラトリーズ・リミテッド ワクチン組成物およびその使用方法
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
JP4688787B2 (ja) * 2003-02-28 2011-05-25 アルカベロ アクチェセルスカプ 糖類マトリックスを有する剤形
EP1709975A1 (en) * 2003-07-10 2006-10-11 Kyowa Hakko Kogyo Co., Ltd. Tablet and process for producing the same
JP5596252B2 (ja) 2003-11-10 2014-09-24 アラーガン、インコーポレイテッド 低用量デスモプレシンを含有する医薬組成物
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
RU2008117396A (ru) 2005-10-04 2009-11-10 Альк-Абелло А/С (Dk) Твердая вакцинная композиция
DK2187926T3 (da) 2007-09-11 2012-04-02 Univ Koebenhavn Forebyggelse af diabetes ved administration af gliadin
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
CN102655878A (zh) * 2009-07-17 2012-09-05 俄克拉荷马州大学评议会 舌上疫苗和施用器
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
WO2012048333A1 (en) * 2010-10-08 2012-04-12 R.P. Scherer Technologies, Llc Oral vaccine fast-dissolving dosage form using starch
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
US11523988B2 (en) * 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
JPH08508247A (ja) * 1993-03-11 1996-09-03 セクレテック,インク. 粘膜表面への免疫原の輸送における重合的粘膜付着体
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery

Similar Documents

Publication Publication Date Title
BRPI9917862A2 (enExample)
JP2001521007A5 (enExample)
JP2001519511A5 (enExample)
JP2002507515A5 (enExample)
JP2002500480A5 (enExample)
IN216564B (enExample)
JP2001516689A5 (enExample)
JP2601441C (enExample)
JP2525961C (enExample)
JP2501707Z (enExample)
JP2582019C (enExample)
JP2576689C (enExample)
JP2551221C (enExample)
JP2545733C (enExample)
JP2501850C (enExample)
JP2544792Z (enExample)
JP2510532C (enExample)
JP2534307C (enExample)
CN3074964S (enExample)
CN3077688S (enExample)
CN3075658S (enExample)
CN3076442S (enExample)
CN3074993S (enExample)
CN3079455S (enExample)
CN3074693S (enExample)